000 01803 a2200481 4500
005 20250517081357.0
264 0 _c20160728
008 201607s 0 0 eng d
022 _a1879-0631
024 7 _a10.1016/j.lfs.2016.02.049
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQuintans-Júnior, Lucindo J
245 0 0 _aβ-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced anti-hyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn.
_h[electronic resource]
260 _bLife sciences
_cMar 2016
300 _a34-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
650 0 4 _aCannabinoids
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aGene Expression Regulation
650 0 4 _aHyperalgesia
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aPolycyclic Sesquiterpenes
650 0 4 _aProto-Oncogene Proteins c-fos
_xantagonists & inhibitors
650 0 4 _aSesquiterpenes
_xadministration & dosage
650 0 4 _aSpinal Cord Dorsal Horn
_xdrug effects
650 0 4 _aTreatment Outcome
650 0 4 _abeta-Cyclodextrins
_xadministration & dosage
700 1 _aAraújo, Adriano A S
700 1 _aBrito, Renan G
700 1 _aSantos, Priscila L
700 1 _aQuintans, Jullyana S S
700 1 _aMenezes, Paula P
700 1 _aSerafini, Mairim R
700 1 _aSilva, Gabriel F
700 1 _aCarvalho, Flavio M S
700 1 _aBrogden, Nicole K
700 1 _aSluka, Kathleen A
773 0 _tLife sciences
_gvol. 149
_gp. 34-41
856 4 0 _uhttps://doi.org/10.1016/j.lfs.2016.02.049
_zAvailable from publisher's website
999 _c25739630
_d25739630